期刊
CELL METABOLISM
卷 25, 期 3, 页码 727-738出版社
CELL PRESS
DOI: 10.1016/j.cmet.2017.01.005
关键词
-
资金
- NIH [R01 DK057846, DP3 DK101122, UC4DK104205]
- JDRF [17-2012-546]
Type 1 diabetes (T1D) is a chronic autoimmune disease that involves immune-mediated destruction of beta cells. How beta cells respond to immune attack is unknown. We identified a population of beta cells during the progression of T1D in non-obese diabetic (NOD) mice that survives immune attack. This population develops from normal beta cells confronted with islet infiltrates. Pathways involving cell movement, growth and proliferation, immune responses, and cell death and survival are activated in these cells. There is reduced expression of beta cell identity genes and diabetes antigens and increased immune inhibitory markers and stemness genes. This new subpopulation is resistant to killing when diabetes is precipitated with cyclophosphamide. Human beta cells show similar changes when cultured with immune cells. These changes may account for the chronicity of the disease and the long-term survival of beta cells in some patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据